Diabeto's technology makes it easier for people with diabetes to upload their blood glucose readings into Diabeto enabled systems, including Livongo's apps.
The companies are targeting availability as soon as possible in 2018 and will continue to explore opportunities to help people better manage their diabetes.
Senseonics, TypeZero and Roche Diabetes Care team-up to trial a long-term artificial pancreas system
The trial will integrate Senseonics' Eversense CGM System with TypeZero's inControl AP algorithms and Roche's Accu-Chek Insight Insulin Pump.
Previously Livongo's service was offered only through employers, health providers, and health plans; Livongo Family Care Plan changes that.
iSage allows physicians to choose from multiple clinically-validated basal insulin algorithms and tailor the algorithms to the patient needs.
The company uses certified diabetes educators (CDE) to reach users via phone calls, texts, emails and other mediums.
BlueStar C is a diabetes health tool designed to aid individuals living with diabetes in managing their chronic condition.
WellDoc has also unveiled its consumer diabetes health app, BlueStar C, to aid individuals living with diabetes manage their chronic condition.
The program supports participants to adopt the dietary, lifestyle and exercise habits aiming to reduce the risk of type 2 diabetes.
The non-exclusive collaboration will combine Novo Nordisk's deep knowledge of diabetes with Glooko's digital platform and data analytics expertise.